Taro to Announce Full Year Results on May 26, 2022
- Wall Street ends up as investors absorb Fed minutes
- Goldman Sachs Cuts Apple Price Target, Sees Stock Plunging to $82 if Deeper Recession
- Walmart (WMT) to Introduce New Fuel and Pickup Fees for Suppliers - WSJ
- Oil slides 2% to 12-week low on fears of global recession
- Just Eat Takeaway (TKAYF) Shares Soar After Amazon Takes Stake in Grubhub Unit
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
HAWTHORNE, N.Y.--(BUSINESS WIRE)-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the year ended March 31, 2022, after the close of market on Thursday, May 26, 2022.
The release will be accessible on Taro’s website at www.taro.com.
Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.
William J. Coote
VP, Chief Financial Officer
Source: Taro Pharmaceutical Industries Ltd.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Resolute Forest Products (RFP) Acquired by The Paper Excellence for $20.50/sh Plus Contingent Rights
- Egan-Jones Releases Risk Commentary - Unintended Consequences (be careful what you wish for)
- 'Perfect Storm is Here': Barclays Cuts Price Targets on US Internet Stocks
Create E-mail Alert Related CategoriesBusiness Wire, Press Releases
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!